1-197065696-T-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001994.3(F13B):​c.64+1464A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.457 in 152,018 control chromosomes in the GnomAD database, including 17,212 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.46 ( 17212 hom., cov: 32)

Consequence

F13B
NM_001994.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.484

Publications

4 publications found
Variant links:
Genes affected
F13B (HGNC:3534): (coagulation factor XIII B chain) This gene encodes coagulation factor XIII B subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as a plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon activation by the cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. [provided by RefSeq, Jul 2008]
F13B Gene-Disease associations (from GenCC):
  • factor XIII, b subunit, deficiency of
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • congenital factor XIII deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.8 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001994.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F13B
NM_001994.3
MANE Select
c.64+1464A>C
intron
N/ANP_001985.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F13B
ENST00000367412.2
TSL:1 MANE Select
c.64+1464A>C
intron
N/AENSP00000356382.2

Frequencies

GnomAD3 genomes
AF:
0.457
AC:
69388
AN:
151900
Hom.:
17195
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.284
Gnomad AMI
AF:
0.550
Gnomad AMR
AF:
0.594
Gnomad ASJ
AF:
0.504
Gnomad EAS
AF:
0.821
Gnomad SAS
AF:
0.605
Gnomad FIN
AF:
0.556
Gnomad MID
AF:
0.430
Gnomad NFE
AF:
0.473
Gnomad OTH
AF:
0.465
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.457
AC:
69455
AN:
152018
Hom.:
17212
Cov.:
32
AF XY:
0.467
AC XY:
34677
AN XY:
74296
show subpopulations
African (AFR)
AF:
0.285
AC:
11808
AN:
41454
American (AMR)
AF:
0.595
AC:
9073
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
0.504
AC:
1748
AN:
3468
East Asian (EAS)
AF:
0.821
AC:
4238
AN:
5164
South Asian (SAS)
AF:
0.604
AC:
2919
AN:
4832
European-Finnish (FIN)
AF:
0.556
AC:
5869
AN:
10560
Middle Eastern (MID)
AF:
0.439
AC:
129
AN:
294
European-Non Finnish (NFE)
AF:
0.473
AC:
32178
AN:
67970
Other (OTH)
AF:
0.469
AC:
991
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1849
3698
5546
7395
9244
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
642
1284
1926
2568
3210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.323
Hom.:
1085
Bravo
AF:
0.456
Asia WGS
AF:
0.708
AC:
2458
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
3.3
DANN
Benign
0.47
PhyloP100
0.48
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2298882; hg19: chr1-197034826; API